Glaukos (GKOS) Gross Profit Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.96% |
| Dec 31, 2025 | -15.19% |
| Sep 30, 2025 | 17.43% |
| Jun 30, 2025 | 57.95% |
| Mar 31, 2025 | 29.28% |
| Dec 31, 2024 | 9.00% |
| Sep 30, 2024 | 7.84% |
| Jun 30, 2024 | 7.59% |
| Mar 31, 2024 | 6.86% |
| Dec 31, 2023 | 6.21% |
| Sep 30, 2023 | 9.46% |
| Jun 30, 2023 | 10.26% |
| Mar 31, 2023 | 10.20% |
| Dec 31, 2022 | 7.84% |
| Sep 30, 2022 | 9.42% |
| Jun 30, 2022 | 8.93% |
| Mar 31, 2022 | 10.50% |
| Dec 31, 2021 | 14.73% |
| Sep 30, 2021 | 18.23% |
| Jun 30, 2021 | 20.05% |
| Mar 31, 2021 | 20.78% |
| Dec 31, 2020 | 26.31% |
| Sep 30, 2020 | 24.49% |
| Jun 30, 2020 | -7.33% |
| Mar 31, 2020 | 13.95% |
| Dec 31, 2019 | 40.19% |
| Sep 30, 2019 | 38.75% |
| Jun 30, 2019 | 42.09% |
| Mar 31, 2019 | 49.39% |